Author

Sandy Dixon

Observed name: S. Dixon

Institution: Pfizer (United States)

Observed institutions: Pfizer (United States), Global Blood Therapeutics (United States)

OpenAlex ID: A5114077641

Improvement in Red Blood Cell Physiology in Children with Sickle Cell Anemia Receiving Voxelotor

2019 · Satheesh Chonat, Earl Fields, et al. · Blood · 14

Pharmacokinetics of Voxelotor in Patients With Renal and Hepatic Impairment

2020 · Richard A. Preston, Thomas Marbury, et al. · The Journal of Clinical Pharmacology · 11

Voxelotor improves red blood cell functionality in children with sickle cell anaemia: An ancillary study of the HOPE‐KIDS 1 trial

2024 · Satheesh Chonat, Earl Fields, et al. · eJHaem · 9

Initial Results from a Cohort in a Phase 2a Study (GBT440-007) Evaluating Adolescents with Sickle Cell Disease Treated with Multiple Doses of GBT440, a HbS Polymerization Inhibitor

2017 · Carolyn C Hoppe, Adlette C. Inati, et al. · Blood · 6

Changes in indicators of cerebral metabolic stress following treatment with voxelotor in children and adolescents with sickle cell anemia

2024 · Andrew M. Heitzer, Ping Zou, et al. · eJHaem · 3

Transcranial Doppler Screening of Children with Sickle Cell Disease for a Large, Multinational Interventional Study: Experience from the Phase 3 HOPE-Kids 2 Trial Investigating the Effect of Voxelotor Treatment on Transcranial Doppler Flow Velocity

2023 · Halima Bello-Manga, Videlis Nduba, et al. · Blood · 3

Voxelotor, which left shifts the oxy-hemoglobin dissociation curve, improves oxygen desaturation in IPF patients during maximal exercise

2019 · Nicholas Vlahakis, Sandy Dixon, et al. · 3

HOPE Kids 2: Phase 3, Randomized Trial of Voxelotor in Children With SCD and Conditional Cerebral Blood Flow Velocities

2026 · Halima Bello‐Manga, Shehu Umar Abdullahi, et al. · American Journal of Hematology · 1

Active Study: Impact of Voxelotor on Sleep Quality, Physical Activity, and Patient-Reported Outcomes

2022 · Nirmish Shah, Clark Brown, et al. · Blood · 1

Voxelotor (GBT440), a Hemoglobin-Oxygen Affinity Modulator, Increases Oxygen Saturation in IPF Patients Who Desaturate with Exercise

2020 · L. Lancaster, H.R. Collard, et al. · 1

Pb2516: Actigraphy Improvement With Voxelotor (active) Study: Impact of Voxelotor on Physical Activity, Fatigue, and Sleep Quality

2023 · Nirmish Shah, Clark Brown, et al. · HemaSphere

Works count: 11

Citation count: 52

H-index: 4

I10-index: 2